A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19

Clinical trial NCT04674189 · COMPLETED

Trial details

NCT number: NCT04674189
Sponsor: CureVac
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Coronavirus Covid19 SARS-CoV-2 Severe Acute Respiratory Syndrome

Start date: 2020-12-23
Primary completion: 2022-06-08
Enrollment: 2357

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.